6 Results

People

  1. Tallman
    Tallman
  2. Adel
    Adel
  3. Jurcic
    Jurcic
  4. Berman
    Berman
  5. Devlin
    Devlin
  6. Frattini
    Frattini
  7. Heaney
    Heaney
  8. Hilden
    Hilden
  9. Rosenblat
    Rosenblat
  10. Akin
    Akin

Groups

  1. Adult Leukemia (6)
  2. Center for Hematologic Malignancies (6)
  3. Department of Medicine (6)
  4. Hematologic Malignancies, Division of (6)
  5. Epidemiology and Biostatistics (3)
  6. Biostatistics Service (2)
  7. Clinical Pharmacy Specialists (2)
  8. GSK Faculty (2)
  9. Advanced Practice Providers (1)
  10. Body Imaging Service (1)
  1. "Nelly Adel"
  2. "Adult Leukemia"
  3. "Meeting abstract"
Formats
  1. Meeting Abstract (6)
Groups
  1. Adult Leukemia (6)
  2. Center for Hematologic Malignancies (6)
  3. Department of Medicine (6)
  4. Hematologic Malignancies, Division of (6)
  5. Epidemiology and Biostatistics (3)
  6. Biostatistics Service (2)

More Groups

People
  1. Nelly Adel (6)
  2. Martin Tallman (4)
  3. Joseph Jurcic (3)
  4. Ellin Berman (2)
  5. Jae Park (2)
  6. Mark Frattini (2)

More People

Years
  1. 2015 (1)
  2. 2014 (1)
  3. 2013 (1)
  4. 2012 (1)
  5. 2011 (2)
Publications
  1. Blood (4)
  2. Journal of Clinical Oncology (2)
Publishers
  1. American Society of Hematology (4)
  2. American Society of Clinical Oncology (2)

Results (6)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Effects of obesity on the efficacy and toxicity of induction chemotherapy in adult acute lymphoblastic leukemia (ALL)
    Meeting Abstract

    Peterson, T. J.; Lin, A.; Hilden, P.; Devlin, S.; Adel, N. G.; Park, J. H.
    Blood (2015)

    Fulltext@MSK | Save
  • Similar incidence of typhlitis in patients receiving various doses of daunorubicin or idarubicin as induction for acute myeloid leukemia
    Meeting Abstract

    Seddon, A. N.; Michael, A. G.; Adel, N. G.; Tallman, M. S.; Akin, O.; Chaim, J.; Drill, E.
    Blood (2014)

    Fulltext@MSK | Save
  • High-dose cytarabine monotherapy versus intermediate or high-dose cytarabine in combination with other agents as second-line salvage therapy In patients with acute myeloid leukemia who did not respond to initial induction therapy
    Meeting Abstract

    Dang, T. O. T.; Hilden, P.; Devlin, S. M.; Rampal, R. K.; Levine, R. L.; Berman, E.; Klimek, V. M.; Adel, N. G.; Tallman, M. S.
    Blood (2013)

    Fulltext@MSK | Save
  • Safety and efficacy of dose escalated liposomal amphotericin B in adult leukemia patients with refractory invasive fungal infections: A single institution report
    Meeting Abstract

    Mathew, S.; Harnicar, S.; Halton, E.; Berman, E.; Brentjens, R. J.; Heaney, M. L.; Jurcic, J. G.; Lamanna, N.; Maslak, P. G.; Rosenblat, T. L.; more...
    Journal of Clinical Oncology (2012)

    Fulltext@MSK | Save
  • Decitabine for the treatment of acute myeloid leukemia (AML): Memorial Sloan-Kettering Cancer Center experience
    Meeting Abstract

    Ganetsky, A.; Adel, N. G.; Frattini, M. G.; Maslak, P. G.; Heaney, M. L.; Jurcic, J. G.; Tallman, M. S.
    Journal of Clinical Oncology (2011)

    Fulltext@MSK | Save
  • Administration of all-trans retinoic acid (ATRA) to newly diagnosed patients (pts) with acute promyelocytic leukemia (APL) is delayed even at experienced centers and associated with an increased early death rate (EDR): A retrospective analysis of 205 pts
    Meeting Abstract

    Altman, J. K.; Rademaker, A.; Cull, E.; Weitner, B. B.; Ofran, Y.; Rosenblat, T. L.; Haidau, A.; Park, J. H.; Ram, S.; Orsini, J.; more...
    Blood (2011)

    Fulltext@MSK | Save